Immunotherapy in lung cancer.
More research and new treatment options are needed in all stages of lung cancer. To this end immunotherapy needs a revival in view of recent improved technologies and greater understanding of the underlying biology. In this review we discuss mechanisms of tumour immunotherapy, non-specific, specific and adoptive, with particular reference to a direct therapeutic action on all subtypes of lung cancer.
M
M
Al-Moundhri
M
M
O'Brien
B E
BE
Souberbielle
D001500:BCG Vaccine / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D016219:Immunotherapy, Adoptive; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000628:therapy*
D001500:BCG Vaccine; D007376:Interleukin-2; D007978:Levamisole; D007372:Interferons